EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype

Meijiao Ma iD, Jinhai Ma, Yuanyuan Lian, Xueli Wu, Wenming Wang, Weining Rong, Xunlun Sheng

Molecular Genetics & Genomic Medicine · 2025

DOI: 10.1002/mgg3.70055 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Meijiao Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gansu Aier Ophthalmology and Optometry Hospital, Lanzhou, China. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Cataract, Monoacylglycerol Lipases, Ataxia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the key research and development project of Ningxia Hui Autonomous Region, Major achievement transformation project of Ningxia Hui Autonomous Region, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

PHARC syndrome, a rare autosomal recessive neurodegenerative disorder caused by mutations in the ABHD12 gene, is characterized by demyelinating polyneuropathy, hearing loss, ataxia, retinitis pigmentosa (RP), and early‐onset cataracts. If patients are first diagnosed in the ophthalmology department, they are easily misdiagnosed as having RP or Usher syndrome. This study aimed to identify the genetic etiology and determine the clinical diagnosis of a Chinese family with suspected PHARC syndrome.

Method

Comprehensive ophthalmic examinations and systemic evaluations were conducted to confirm the phenotype. The genotype was identified through Whole Exome Sequencing (WES), and the current literature was reviewed understand better manifestations of PHARC syndrome related to pathogenic variants.

Results

The principal symptoms of the proband comprised profound sensorineural hearing loss since childhood, severe visual impairment, congenital cataracts, cone‐rod dystrophy, and ataxia. WES revealed that the proband carried a compound heterozygous variant in the ABHD12 gene: M1, a known nonsense variation c.477G > A (p.Trp159Ter); and M2, a novel copy number variant with a deletion of approximately 18.10 Kbp in chromosome 20p11.21 (seq[GRCh38]del(20) (p11.21)chr20:g. 25302218_25320318del), covering exons 4–12 of the ABHD12 gene. The literature review indicated that there were 65 patients with PHARC from 30 different families. All clinical information of the described patients with PHARC syndrome and all known mutations associated with the disease to date were compiled.

Conclusion

This study expands the spectrum of pathogenic variants and phenotype for PHARC syndrome and suggests genetic testing is necessary for a definitive diagnosis of PHARC syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinitis PigmentosaCataractMonoacylglycerol LipasesAtaxiaPolyneuropathiesHearing Loss, SensorineuralHumansMaleFemalePedigreePhenotypeHeterozygoteAdultMutationEast Asian People

Stichwörter der Autor:innen

ABHD12ChinesePHARCnew genotype‐phenotype

Substanzen

ABHD12 protein, humanMonoacylglycerol Lipases

Autor:innen und Institutionen

  • Gansu Aier Ophthalmology and Optometry Hospital, Lanzhou, China.
  • Lanzhou Brigtt Eye Hospital Lanzhou, Lanzhou, China.
  • Ningxia Eye Hospital, People's Hospital of Ningxia Hui Autonomous Region, Third Clinical Medical College of Ningxia Medical University, Yinchuan, China.

ORCID-Profile: Meijiao Ma

Förderung

  • the key research and development project of Ningxia Hui Autonomous Region
  • Major achievement transformation project of Ningxia Hui Autonomous Region
  • National Natural Science Foundation of China

Zitieren

APA

Ma, M., Ma, J., Lian, Y., Wu, X., Wang, W., Rong, W., & Sheng, X. (2025). A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70055

Vancouver

Ma M, Ma J, Lian Y, Wu X, Wang W, Rong W, et al. A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70055

BibTeX
@article{Ma2025,
  author = {Ma, Meijiao and Ma, Jinhai and Lian, Yuanyuan and Wu, Xueli and Wang, Wenming and Rong, Weining and Sheng, Xunlun},
  title = {A Novel Compound Heterozygous Variant in the ABHD12 Gene Cause PHARC Syndrome in a Chinese Family: The Proband Presenting New Genotype and Phenotype},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2025},
  doi = {10.1002/mgg3.70055}
}
Kostenlos starten →